Natera

Medical Director, General Oncology

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical DevicesIndustries

Position Overview

  • Location Type: Remote with ~50% domestic and international travel
  • Job Type: Full-time
  • Salary: Not specified

Shape the future of cancer care as a Medical Director, General Oncology at Natera. In this strategic leadership role, you will provide medical expertise for Natera’s oncology portfolio, collaborating with cross-functional teams across research, development, commercial, and medical affairs. You will ensure the scientific integrity and clinical adoption of our oncology testing solutions.

Primary Responsibilities

  • Clinical Development:
    • Collaborate with the Chief Medical Officer and other Medical Directors in Oncology on the clinical development of ctDNA-based diagnostics.
    • Lead development and implementation of clinical strategies for Natera’s oncology products.
  • Medical Education and Communication:
    • Oversee medical education and scientific communication for healthcare providers on Natera’s oncology offerings.
    • Partner with the commercial team to develop and deliver compelling medical messages for Natera’s oncology products.
  • Representation and Advocacy:
    • Represent Natera at medical conferences and industry events, in person and virtual.
    • Foster a culture of scientific excellence and intellectual curiosity within the oncology team.
  • Research and Development:
    • Collaborate with research and development teams on clinical trial design, data analysis, and publication.

Key Skill Sets / Responsibilities

  • Oncology Specific Expertise:
    • Strong knowledge in general oncology.
    • Provide expert guidance and support on oncology cases and clinical trials.
  • Comprehensive Oncology Knowledge:
    • Ability to speak to all histologies and indications, ensuring broad expertise across the oncology spectrum.
    • Stay updated on the latest advancements in various cancer types and integrate this knowledge into Natera’s oncology products.
  • Cross-Disciplinary Collaboration:
    • Work effectively with cross-functional teams including research, development, commercial, and medical affairs to drive the success of oncology initiatives.
    • Coordinate with internal and external stakeholders to ensure the clinical relevance and adoption of Natera’s oncology solutions.

Qualifications

  • M.D. or D.O. degree with board certification in Hematology/Oncology (required).
  • At least 5 years of experience in oncology (required), with a background in clinical research and development (preferred).
  • Clinical experience and strong knowledge related to the management of patients with solid tumors.

Application Instructions

  • Not specified

Company Information

  • Company: Natera
  • Industry: Biotechnology

Skills

Oncology
Clinical Development
Medical Education
Scientific Communication
Research and Development
Clinical Trial Design
Data Analysis
Medical Leadership
Cross-Functional Collaboration
Industry Representation

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI